Elan
113 results

Perrigo executives head for Israel in battle against Mylan
- Health & Pharma
- October 26, 2015, 16:05
Top executives of Dublin-based over-the-counter drug company Perrigo arrived in Israel today for meetings with investors as they seek to fend off a ho(...)

Life sciences investment group Malin loses €9.6m in first half
- Health & Pharma
- September 21, 2015, 21:25
Listed life sciences investment group Malin has reported its maiden set of results. Excluding the costs of establishing the company, Malin reported a (...)

Perrigo files lawsuit against suitor Mylan
- Health & Pharma
- September 18, 2015, 18:09
Irish over-the-counter drug company Perrigo has filed a lawsuit against suitor Mylan in a Manhattan court. The legal action comes as Perrigo urged its(...)

Cantillon: Don’t expect dividends in Mylan offer
- Health & Pharma
- September 15, 2015, 01:00
Shareholders in over-the-counter drug specialists Perrigo receive their latest quarterly dividend today. It comes as they mull the formal offer for th(...)

Malin appoints former Elan boss Kelly Martin as chief executive
- Health & Pharma
- August 24, 2015, 14:15
Irish life sciences investment firm Malin completed its initial series of asset purchases with two more investments on Monday and said director and fo(...)

Alkermes looks to schizophrenia drug approval as sales jump 24%
- Health & Pharma
- April 30, 2015, 21:02
Revenue at Irish drug group Alkermes jumped almost 24 per cent in the first three months of the year, to $161.2 million, ahead of analyst expectations(...)

Perrigo rejects $29bn bid from generics group Mylan
- Health & Pharma
- April 22, 2015, 09:23
Dublin-based Perrigo has rejected a $29 billion bid from generics group Mylan. The company said its board unanimously rejected the $205 per share offe(...)

Fountain Healthcare Partners secures €15m from AIB for life sciences fund
- Financial Services
- April 10, 2015, 01:00
AIB has committed €15 million to a dedicated life-sciences venture-capital fund managed by Dublin-based Fountain Healthcare Partners. AIB is investing(...)

Generics group Mylan swoops on rival Perrigo with $28.9bn deal
- Health & Pharma
- April 8, 2015, 20:28
Drugmaker Mylan offered to buy rival Perrigo for $28.9 billion in a deal that would create a powerhouse for generic medicine. Mylan, which makes abo(...)

Elan gene pool continues to deliver
- Health & Pharma
- February 28, 2015, 01:00
The Elan gene pool delivers once again. It would be wrong to suggest that the business – since subsumed into generics and over-the-counter specialist (...)